Try our Advanced Search for more refined results
September 28, 2017
NEW ENGLAND CARPENTERS HEALTH BENEFITS FUND v. CELGENE CORPORATION
Case Number:
2:17-cv-07637
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
September 29, 2017
Celgene Hit With Expansive Antitrust Suit Over Thalomid
A health fund hit Celgene Corp. with a proposed class action Thursday in New Jersey federal court over the company's alleged anti-competitive behavior meant to keep its monopoly on the drugs Thalomid and Revlimid, including abusing a drug safety protocol, fraudulently obtaining patents and filing sham patent suits.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login